Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BA vs MRNA✓SelectedUSD · MRNABA vs MRNA performance historyLatest closeAs of-3.66%11/16
Stock and ETF performance explorer

BA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-13.9%
MRNA return
+778.7%
Excess return
-792.5%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.7%-3.6%0.0%-3.6%
7D-4.2%-20.0%+15.8%-3.8%
30D-13.1%-1.3%-11.9%-13.1%
3M-28.7%+240.0%-268.7%-30.6%
6M-25.1%+339.0%-364.0%-30.1%
YTD-23.9%+630.0%-653.9%-33.5%
All-13.9%+778.7%-792.5%-26.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling